BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30532175)

  • 1. MicroRNA isolation and quantification in cerebrospinal fluid: A comparative methodical study.
    Kopkova A; Sana J; Fadrus P; Machackova T; Vecera M; Vybihal V; Juracek J; Vychytilova-Faltejskova P; Smrcka M; Slaby O
    PLoS One; 2018; 13(12):e0208580. PubMed ID: 30532175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of RNA isolation methods for microRNA quantification in a range of clinical biofluids.
    Roest HP; IJzermans JNM; van der Laan LJW
    BMC Biotechnol; 2021 Aug; 21(1):48. PubMed ID: 34362351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usage of Cerebrospinal Fluid for microRNA Analysis].
    Kopková A; Šána J; Večeřa M; Knoflíčková D; Smrčka M; Slabý O; Fadrus P
    Klin Onkol; 2018; 31(Supplementum1):158-160. PubMed ID: 29808693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors.
    Kopkova A; Sana J; Fadrus P; Slaby O
    Clin Chem Lab Med; 2018 May; 56(6):869-879. PubMed ID: 29451858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients.
    Akers JC; Ramakrishnan V; Kim R; Phillips S; Kaimal V; Mao Y; Hua W; Yang I; Fu CC; Nolan J; Nakano I; Yang Y; Beaulieu M; Carter BS; Chen CC
    J Neurooncol; 2015 Jun; 123(2):205-16. PubMed ID: 25903655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNAs in the cerebrospinal fluid of patients with brain diseases.
    Machida A; Ohkubo T; Yokota T
    Methods Mol Biol; 2013; 1024():203-9. PubMed ID: 23719953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity.
    Teplyuk NM; Mollenhauer B; Gabriely G; Giese A; Kim E; Smolsky M; Kim RY; Saria MG; Pastorino S; Kesari S; Krichevsky AM
    Neuro Oncol; 2012 Jun; 14(6):689-700. PubMed ID: 22492962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Customized Quantitative PCR MicroRNA Panel Provides a Technically Robust Context for Studying Neurodegenerative Disease Biomarkers and Indicates a High Correlation Between Cerebrospinal Fluid and Choroid Plexus MicroRNA Expression.
    Wang WX; Fardo DW; Jicha GA; Nelson PT
    Mol Neurobiol; 2017 Dec; 54(10):8191-8202. PubMed ID: 27900678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs in Cerebrospinal Fluid as Biomarkers in Brain Tumor Patients.
    Kopková A; Šána J; Večeřa M; Fadrus P; Lipina R; Smrčka M; Lojová M; Slabý O
    Klin Onkol; 2019; 32(3):181-186. PubMed ID: 31216849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiRNA profiles in cerebrospinal fluid from patients with central hypersomnias.
    Holm A; Bang-Berthelsen CH; Knudsen S; Modvig S; Kornum BR; Gammeltoft S; Jennum PJ
    J Neurol Sci; 2014 Dec; 347(1-2):199-204. PubMed ID: 25451005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in microRNA recovery from plasma: Comparison of five commercial kits.
    Brunet-Vega A; Pericay C; Quílez ME; Ramírez-Lázaro MJ; Calvet X; Lario S
    Anal Biochem; 2015 Nov; 488():28-35. PubMed ID: 26271186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer.
    Campomenosi P; Gini E; Noonan DM; Poli A; D'Antona P; Rotolo N; Dominioni L; Imperatori A
    BMC Biotechnol; 2016 Aug; 16(1):60. PubMed ID: 27538962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Urinary MicroRNAs by Quantitative Polymerase Chain Reaction in Diabetic Nephropathy Patients.
    Newbury LJ; Wonnacott A; Simpson K; Bowen T; Fraser D
    Methods Mol Biol; 2020; 2067():277-285. PubMed ID: 31701457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of miRNA isolation and RT-qPCR technologies and their effects on quantification accuracy and repeatability.
    Redshaw N; Wilkes T; Whale A; Cowen S; Huggett J; Foy CA
    Biotechniques; 2013 Mar; 54(3):155-64. PubMed ID: 23477383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA Changes in Cerebrospinal Fluid After Subarachnoid Hemorrhage.
    Bache S; Rasmussen R; Rossing M; Laigaard FP; Nielsen FC; Møller K
    Stroke; 2017 Sep; 48(9):2391-2398. PubMed ID: 28768799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.
    Lusardi TA; Phillips JI; Wiedrick JT; Harrington CA; Lind B; Lapidus JA; Quinn JF; Saugstad JA
    J Alzheimers Dis; 2017; 55(3):1223-1233. PubMed ID: 27814298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid MicroRNA profiling using quantitative real time PCR.
    Pacifici M; Delbue S; Kadri F; Peruzzi F
    J Vis Exp; 2014 Jan; (83):e51172. PubMed ID: 24514260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and quantification of microRNA in cerebral microdialysate.
    Bache S; Rasmussen R; Rossing M; Hammer NR; Juhler M; Friis-Hansen L; Nielsen FC; Møller K
    J Transl Med; 2015 May; 13():149. PubMed ID: 25947950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA expression profiling of cerebrospinal fluid in patients with aneurysmal subarachnoid hemorrhage.
    Stylli SS; Adamides AA; Koldej RM; Luwor RB; Ritchie DS; Ziogas J; Kaye AH
    J Neurosurg; 2017 Apr; 126(4):1131-1139. PubMed ID: 27128592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid.
    Müller M; Kuiperij HB; Claassen JA; Küsters B; Verbeek MM
    Neurobiol Aging; 2014 Jan; 35(1):152-8. PubMed ID: 23962497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.